Mineralys Therapeutics
MLYS
MLYS
77 hedge funds and large institutions have $252M invested in Mineralys Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
41% less capital invested
Capital invested by funds: $429M → $252M (-$177M)
Holders
77
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$14M | |
| 2 | +$5.41M | |
| 3 | +$4.35M | |
| 4 |
Millennium Management
New York
|
+$3.46M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$2.76M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$13.1M | |
| 3 | -$9.31M | |
| 4 |
Jennison Associates
New York
|
-$6.06M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.51M |